Status | Study |
Recruiting |
Study Name: Natural History Study of Children and Young Adults With Medullary Thyroid Cancer Condition: Medullary Thyroid Carcer Date: 2012-08-07 |
Completed |
Study Name: Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients Condition: Medullary Thyroid Carcinoma Multiple Endocrine Neoplasia Type 2 Date: 2011-08-26 |
Completed |
Study Name: High Dose Somatostatin Analogues in Neuroendocrine Tumors Condition: Respiratory Tract Neoplasms Thymic Neoplasms Pancreatic Ne Date: 2009-10-05 Interventions: Drug: Octreotide-LAR Octreotide-LAR 30 mg administered every 21 days until progression |
Terminated |
Study Name: A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors Condition: Neuroendocrine Tumors Carcinoid Tumors Adrenal Gland Tumor Date: 2009-07-23 Interventions: Drug: pertuzumab 840 mg, 420 m |
Completed |
Study Name: Vancomycin Associated Red Man Syndrome (RMS) Condition: Red Man Syndrome Date: 2009-01-14 |
Active, not recruiting |
Study Name: Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer Condition: Medullary Thyroid Carcinoma Multiple Endocrine Neoplasia Type 2 Date: 2007-08-08 Interventions: Drug: Vandetanib once daily continuously (28 day cycles) |
Active, not recruiting |
Study Name: Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes Condition: Multiple Endocrine Neoplasia Date: 2007-07-12 Interventions: Behavioral: Questionnaire Mailed packets including cover letter describing purpose of study, study quest |
Completed |
Study Name: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer Condition: Gastrin-Producing Neuroendocrine Tumor Lung Carcinoid Tumor Date: 2007-03-27 Interventions: Other: Laboratory Biomarker Analysis |
Active, not recruiting |
Study Name: Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer Condition: Multiple Endocrine Neoplasia Recurrent Thyroid Gland Carcinoma Date: 2006-10-18 Interventions: Other: Laboratory Biomarker Analysis |
Completed |
Study Name: Cinacalcet to Treat Familial Primary Hyperparathyroidism Condition: Hypercalcemia Familial Primary Hyperparathyroidism Date: 2006-05-11 Interventions: Procedure: Parathyroid hormone testing Pro |